everything you need to know about biomarker testing and treatment of genomically altered nsclc
Published 3 years ago • 491 plays • Length 1:39:03Download video MP4
Download video MP3
Similar videos
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies
-
1:04:49
everything you need to know about molecular testing and targeted therapies in nsclc
-
1:03:55
the nuances of immunotherapy biomarker testing in solid tumors
-
1:07:31
precision decisions in genomic testing and targeted treatment of nsclc
-
59:37
refining biomarker testing and targeted treatment of nsclc with egfr mutations
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
1:25:15
decoding biomarker testing and targeted therapy in nsclc
-
1:02:02
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
1:02:08
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
1:14:14
fine-tuning biomarker testing to identify and target ret fusions in nsclc
-
58:57
navigating the complexities of biomarker testing in the expanding field of precision immuno-oncology
-
1:42
ask ruby: what is biomarker testing?
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
1:00:20
it’s precisely the time for more precision in genomic testing and targeted treatment of nsclc
-
5:50
how is biomarker testing carried out?
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
6:22
biomarker testing in stage iii nsclc